Cerebrospinal fluid metabolites as potential biomarkers for epilepsy: Insights from genome‐wide association studies
Abstract Objectives While metabolic imbalances have been observed in individuals with epilepsy, the direct involvement of specific metabolites in the development of the condition remains underexplored. A comprehensive analysis of the causality between cerebrospinal fluid metabolites (CSF) and epilep...
Saved in:
Main Authors: | Zhenxiang Zhao, Na Xing, Lin Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.13101 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
by: Run Peng, et al.
Published: (2025-02-01) -
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
Exploratory profiling of metabolites in cerebrospinal fluid using a commercially available targeted LC-MS based metabolomics kit to discriminate leptomeningeal metastasis
by: Soojin Jang, et al.
Published: (2025-01-01) -
An Improved Method for Extracting Rat Cerebrospinal Fluid with Repeatable Large-Scale Collection
by: Limei Wang, et al.
Published: (2025-01-01) -
Transcranial vibration stimulation at 40 Hz induced neural activity and promoted the coupling of global brain activity and cerebrospinal fluid flow
by: Linghan Kong, et al.
Published: (2025-03-01)